A new 1:1 drug-drug cocrystal of theophylline (THP) and aspirin (ASP) was successfully prepared by liquid assisted grinding, evaporative crystallization, and slurry conversion crystallization. The obtained cocrystal was comprehensively characterized by single crystal X-ray diffraction, powder X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, scanning electron microscopy, and Fourier transform infrared analysis. Ternary phase diagrams were constructed for the obtained cocrystal in isopropyl alcohol at two different temperatures, i.e., 20 and 40 °C. A narrow stability region was found for the pure THP-ASP cocrystal in the phase diagram at both temperatures. By proper selection of the ratios between THP, ASP, an...
Designing co-crystals can be considered as a commonly used strategy to improve the bioavailability o...
The stability of different theophylline cocrystals under milling conditions was investigated by comp...
To identify as many solid forms of active pharmaceutical ingredient (API) as possible and to monitor...
A new 1:1 drug-drug cocrystal of theophylline (THP) and aspirin (ASP) was successfully prepared by l...
A new 1:1 drug-drug cocrystal of theophylline (THP) and aspirin (ASP) was successfully prepared by l...
To obtain new crystal forms with altered physicochemical properties and to get insight into the driv...
Pharmaceutical co-crystallization has been a recent focus because of its potential to improve the ef...
Two new cocrystals of theophylline were prepared by liquid assisted grinding. While compound 1 (theo...
In recent years, there has been an increasing interest in cocrystallization of active pharmaceutical...
Theophylline, a pharmaceutical model compound, was screened for cocrystal formation using nine (di)...
Pharmaceutical cocrystals of nonsteroidal anti-inflammatory drugs diflunisal (DIF) and diclofenac (D...
To obtain new crystal forms with altered physicochemical properties and to get insight into the driv...
Two new cocrystals of theophylline were prepared by liquid assisted grinding. While compound <b>1</b...
Designing co-crystals can be considered as a commonly used strategy to improve the bioavailability o...
The stability of different theophylline cocrystals under milling conditions was investigated by comp...
To identify as many solid forms of active pharmaceutical ingredient (API) as possible and to monitor...
A new 1:1 drug-drug cocrystal of theophylline (THP) and aspirin (ASP) was successfully prepared by l...
A new 1:1 drug-drug cocrystal of theophylline (THP) and aspirin (ASP) was successfully prepared by l...
To obtain new crystal forms with altered physicochemical properties and to get insight into the driv...
Pharmaceutical co-crystallization has been a recent focus because of its potential to improve the ef...
Two new cocrystals of theophylline were prepared by liquid assisted grinding. While compound 1 (theo...
In recent years, there has been an increasing interest in cocrystallization of active pharmaceutical...
Theophylline, a pharmaceutical model compound, was screened for cocrystal formation using nine (di)...
Pharmaceutical cocrystals of nonsteroidal anti-inflammatory drugs diflunisal (DIF) and diclofenac (D...
To obtain new crystal forms with altered physicochemical properties and to get insight into the driv...
Two new cocrystals of theophylline were prepared by liquid assisted grinding. While compound <b>1</b...
Designing co-crystals can be considered as a commonly used strategy to improve the bioavailability o...
The stability of different theophylline cocrystals under milling conditions was investigated by comp...
To identify as many solid forms of active pharmaceutical ingredient (API) as possible and to monitor...